Testosterone hormone concentration (ng\ml): The concentration of testosterone hormone was showed in Figure (1). The result register that non-significant (P ˃ 0.05) difference in testosterone concentration in all treated group as a compared with control group at zero time. While, the result elucidated that was a significant (P ˂ 0.05) elevation of testosterone concentration in G2, G3 and G4 group as a compared with control and G1 treated group at 28 day of treatment. Also showed significant (P ˂ 0.05) elevation of testosterone concentration in G4 treated group as a compared with control and G1 and G2 group at 56 day of experiment period. Whereas, G3 group was showed significant (P˂ 0.05) elevation of testosterone concentration when a compared with control and G1 group at 56 day of administration.
Figure (2) refer to the testosterone concentration among the time of administration, the result was showed a significant (P ˂ 0.05) increment of testosterone concentration in all treated group at 56 day of experiment period when compared with zero time of treated period. While the data was showed a significant (P ˂ 0.05) increment of testosterone concentration in G3 treated group at 28 day of administration as a compared with zero time.
Luteinizing hormone concentration (mlU\ml): The mean values of luteinizing hormone concentration (mlU\ml) in adult male rats treated with serial dose of ZnONPs (5, 10, 20 and 40 mg/kg B.W) synthesized from PPE are clarified in figure (3). Non-significant (P > 0.05) differences in serum concentration of LH are observed in all treated groups at zero time and 28 day of experiment period as a compared with control group. Whereas there was a significant (P< 0.05) decrement in serum LH concentration was registered in all treated group as a compared with control group at 56 day of ZnONPs administration period.
Furthermore, the data in Figure (4) showed a significant (P< 0.05) decrease in serum LH concentration in all treated group at 56 day of experiment period when a compared with zero time and 28 day of experiment period.

Figure 1: Represent the effect of different doses of ZnONPs was synthesized by PPE on serum testosterone concentration (ng\ml ) in adult male rats along 56 day of treatment.

Figure 2: Represent the effect of different doses of ZnONPs was synthesized by PPE on serum testosterone concentration (ng\ml ) in adult male rats in zero time, 28day and 56 day of treatment.

Figure 3: Represent the effect of different doses of ZnONPs was synthesized by PPE on serum LH concentration (mlU\ml) in adult male rats after 56 day of treatment.

Figure 4: Represent the effect of different dose of ZnONPs was synthesized by PPE on LH concentration (mlU\ml) in adult male rats, in zero time, 28day and 56 day of treatment.

Figure 5: Represent the effect of different doses of ZnONPs was synthesized by PPE on serum FSH concentration (mlU\ml) in adult male rats after 56 day of treatment.
Serum FSH concentration (mlU\ml): Figure (5) refer to the results of FSH concentration (mlU\ml) before and after treated with of ZnONPs synthesized from PPE in adult male rats. FSH concentration at zero time is showed non-significant (P ˃ 0.05) differences in all treated group when compared with control group. Serum follicular stimulating hormone concentration showed a significant (P < 0.05) elevation in G4 treated group at (28 and 56 day) of ZnONPs administration when a compared with control group, while there was non-significant (P ˃ 0.05) differences between G1, G2 and G3 as a compared with control group at the same two periods. From our date in histogram Figure (6) demonstrate significant (P < 0.05) elevation in FSH concentration in G4 group at 56 day of experiment as a compared with zero and 28 of experiment. Between the same group, the concentration of serum FSH was showed in histogram Figure (6). Group treated with 40 mg/kg B.W (G4) of ZnONPs was registered a significant (P < 0.05) increment at 56 day as a compared with zero time and (28 day) in same treated group. Whereas, there were non-significant (P ˃ 0.05) differences in serum FSH concentration in other treated groups at (28 day and 56 day) as a compared with zero time of experiment period.

Figure 6: Represent the effect of different doses of ZnONPs was synthesized by PPE on Serum FSH concentration (mlU\ml) in adult male rats in zero time, 28day and 56 day of treatment.

Figure 7: Represent the different doses of ZnONPs was synthesized by PPE on Inhibin B concentration (pg\ml) in adult male rats after 56 day of treatment
Inhibin_B hormone concentration (pg\ml): In this study, the data revealed the effect of zinc oxide nanoparticles in variance doses on the serum concentration of Inhibin B hormone (Figure 7). The results of healthy animals treated with ZnONPs showed significant (P < 0.05) decrease in serum concentration of Inhibin B hormone in G4 treated group at 28 day of experiment period as a compared with control group in same time of treatment. On the other hand, the serum concentration of Inhibin B hormone is registered significant (P < 0.05) decrement in all treated groups with all different dose of ZnONPs at day 56 of administration as a compared with control group. Within time the Inhibin B hormone concentration illustrated in Figure (8) was showed significant (P < 0.05) decrement in all treated group at 56 day of experiment period when a compared with zero time and 28 day of administration accept G4 treated group are non-significant (P>0.05) differences in Inhibin B concentration at 56 day when a compared with 28 day of treatment.

Figure 8: Represent the different doses of ZnONPswas synthesized by PPE on serum Inhibin B concentration (pg\ml) in adult male rats in zero time, 28day and 56 day of treatment.